HF1271

This Minnesota House bill (H.F. No. 1271) seeks to modify existing laws regarding the sale and regulation of hemp-derived cannabinoid products. Key provisions include:

1. Regulation of Cannabinoid Sales:

   • Non-intoxicating cannabinoids, including edible products, can be sold for human or animal consumption if they meet legal requirements.
     
   • Products must not contain more than 0.3% tetrahydrocannabinol (THC), and edible products must adhere to established THC limits.
     
   • Non-edible cannabinoid-containing products must be for external use only and cannot be consumed through inhalation, ingestion, or injection.
     
   • Cannabinoids cannot be marketed for treating diseases or affecting bodily functions.
     

2. Age Restriction:

   • No cannabinoid or THC-containing products may be sold to individuals under 21.
     

3. Onsite Consumption Rules:

   • Products can be sold for onsite consumption if the retailer also holds a liquor license.
     
   • Products must remain in their original packaging except for statutory exceptions.
     
   • Consumers cannot mix cannabinoid products with alcohol or take removed packaging off-premises.
     

4. Hemp Edible Manufacturing Standards:

   • Manufacturers must comply with state and local building, fire, and zoning regulations.
     
   • Licensed premises must be kept clean and free of infestation.
     

5. Labeling Requirements for Hemp-Derived Topical Products:

   • Packages must include details such as the manufacturer’s information, lab testing details, product weight, cannabinoid content, ingredient list, and disclaimers.
     
   • Certain information may be provided via a scannable barcode linking to a website.
     

6. Prohibitions on Sale and Manufacturing:

   • Products cannot be marketed or used for disease treatment.
     
   • Inhalable, chewable, injectable, or improperly diluted products are prohibited.
     
   • Products must not contain harmful additives, contaminants, or incorrect cannabinoid amounts.
     

Overall, this bill aims to enhance consumer protections, clarify licensing requirements, and ensure the safe sale and labeling of hemp-derived cannabinoids in Minnesota.